This case highlights the benefits of diligent early identification of arginine vasopressin resistance to effectively manage the condition and reduce the risk of further acute kidney injury, life-threatening hypernatremia and metabolic derangements, and associated prolonged hospitalization and morbidity risk. The gene discussed is AVP; the disease is acute kidney injury.